Oruka Therapeutics Inc. (ORKA)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$32.82
Day's range
$35.64

Oruka Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 7.43 M $364.51 M   2.34% 16.29%
VR ADVISER, LLC 05/15/2026 4.15 M $203.48 M   0.00% 9.09%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2026 3.71 M $181.74 M   0.00% 8.12%
BLACKROCK, INC. 05/13/2026 3.53 M $173.00 M   -0.35% 7.73%
VIKING GLOBAL INVESTORS LP 05/15/2026 2.67 M $130.80 M   0.00% 5.85%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2026 2.32 M $113.81 M   35.67% 5.09%
RTW INVESTMENTS, LP 05/15/2026 2.06 M $100.95 M   0.00% 4.51%
DEEP TRACK CAPITAL, LP 05/15/2026 2.03 M $99.78 M   -5.89% 4.46%
05/15/2026 1.86 M $91.21 M   100.00% 4.08%
STATE STREET CORP 05/15/2026 1.61 M $79.14 M   16.59% 3.54%
05/19/2026 1.57 M $76.80 M   0.85% 3.43%
PERCEPTIVE ADVISORS LLC 05/29/2026 1.40 M $68.45 M   -5.49% 3.06%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.05 M $51.39 M   7.09% 2.30%
CITADEL ADVISORS LLC 05/15/2026 1.01 M $49.42 M   38.76% 2.21%
FRANKLIN RESOURCES INC 05/13/2026 1.00 M $49.25 M   6.99% 2.20%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 954.87 K $46.85 M   1.31% 2.09%
MERCER GLOBAL ADVISORS INC /ADV 05/15/2026 802.47 K $39.36 M   7.67% 1.76%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 760.42 K $37.30 M   15.14% 1.67%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 727.45 K $35.68 M   12.03% 1.59%
WOODLINE PARTNERS LP 05/15/2026 574.88 K $28.20 M   0.06% 1.26%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 533.34 K $26.16 M   0.00% 1.17%
BELLEVUE GROUP AG 05/15/2026 507.01 K $24.87 M   100.00% 1.11%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 499.67 K $24.51 M   -37.72% 1.10%
SYNERGY ASSET MANAGEMENT, LLC 05/13/2026 476.20 K $23.36 M   3.76% 1.04%
SR ONE CAPITAL MANAGEMENT, LP 05/14/2026 430.33 K $21.11 M   0.00% 0.94%
CANDRIAM S.C.A. 04/30/2026 411.01 K $20.16 M   2.62% 0.90%
05/08/2026 350.89 K $17.21 M   100.00% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 321.95 K $15.79 M   -2.29% 0.71%
WESTFIELD CAPITAL MANAGEMENT CO LP 05/11/2026 313.13 K $15.36 M   100.00% 0.69%
NORTHERN TRUST CORP 05/14/2026 299.04 K $14.67 M   6.46% 0.66%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 257.07 K $12.61 M   100.00% 0.56%
GOLDMAN SACHS GROUP INC 05/15/2026 246.71 K $12.10 M   165.29% 0.54%
IKARIAN CAPITAL, LLC 05/15/2026 242.02 K $11.87 M   100.00% 0.53%
ATIKA CAPITAL MANAGEMENT LLC 05/14/2026 229.90 K $11.28 M   100.00% 0.50%
UBS GROUP AG 05/05/2026 212.27 K $10.41 M   -21.68% 0.47%
CABLE CAR CAPITAL LLC 05/15/2026 200.00 K $9.81 M   -50.00% 0.44%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 190.03 K $9.32 M   100.00% 0.42%
HOLOCENE ADVISORS, LP 05/15/2026 185.51 K $9.10 M   100.00% 0.41%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 184.86 K $9.07 M   84.86% 0.41%
GREAT POINT PARTNERS LLC 05/15/2026 183.33 K $8.99 M   0.00% 0.40%
JENNISON ASSOCIATES LLC 05/06/2026 176.68 K $8.67 M   100.00% 0.39%
MORGAN STANLEY 05/15/2026 175.45 K $8.61 M   43.58% 0.38%
PFM HEALTH SCIENCES, LP 05/15/2026 174.05 K $8.54 M   100.00% 0.38%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 150.91 K $7.40 M   100.00% 0.33%
05/14/2026 140.84 K $6.91 M   100.00% 0.31%
DEUTSCHE BANK AG\ 05/06/2026 140.79 K $6.91 M   17.98% 0.31%
LONGAEVA PARTNERS L.P. 05/15/2026 136.88 K $6.71 M   6.85% 0.30%
MOODY ALDRICH PARTNERS LLC 04/20/2026 135.06 K $6.62 M   6.50% 0.30%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 132.50 K $6.50 M   12.17% 0.29%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 126.37 K $6.20 M   159.55% 0.28%

Oruka Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 197 institutional investors and hedge funds held shares of Oruka Therapeutics Inc.. The most heavily invested institutionals were:

FMR LLC: 7.43 M

VR Adviser, LLC: 4.15 M

Fairmount Funds Management LLC: 3.71 M

BlackRock, Inc.: 3.53 M

VIKING GLOBAL INVESTORS LP: 2.67 M

Paradigm Biocapital Advisors LP: 2.32 M

114.04% of Oruka Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 50.50 M shares in the last 24 months. This purchase volume represents approximately $1.70 B in transactions.